Citizens Downgrades Terns Pharmaceuticals (TERN) to Market Perform

March 26, 2026 3:39 AM

Citizens analyst Silvan Tuerkcan downgraded Terns Pharmaceuticals (NASDAQ: TERN) from Market Outperform to Market Perform.The analyst comments: "Merck and Terns ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found